Acute Kidney Injury in Pediatric Patients

Initial Assessment and Diagnosis

• The American Academy of Pediatrics recommends measuring serum creatinine and BUN, and calculating estimated GFR using the revised Schwartz Formula to assess renal function in children 1
• Serum creatinine alone should not be used to assess renal function in children, as recommended by the National Kidney Foundation 1
• The pRIFLE criteria are recommended for AKI assessment in children over 1 month, according to the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines 2
• Cystatin C may be more accurate than creatinine for GFR estimation in children, as suggested by the European Society of Pediatric Nephrology 1

Age-Specific Variations

• Neonates have immature renal function with limited ability to concentrate urine, as reported by the American Academy of Pediatrics 3
• Maternal creatinine influence immediately after birth should be considered when interpreting serum creatinine levels in neonates, as noted by the American Society of Nephrology 4

Measurement Challenges and Recovery Patterns

• The Kidney Disease: Improving Global Outcomes (KDIGO) guidelines recommend using multiple indices and clinical context to diagnose AKI, as no single test is definitive 2
• Prerenal failure typically resolves within 7 days with appropriate treatment, but postrenal and intrinsic renal failure require longer recovery periods, as reported by the Society of Pediatric Research 2
• Serum creatinine in neonates initially reflects maternal levels and decreases over the first weeks of life, as described by the American Academy of Pediatrics 4

Diagnostic Indices and Imaging Studies

• The National Kidney Foundation recommends calculating key diagnostic indices, including FENa, RFI, and FEUrea, to differentiate between prerenal and postrenal causes of AKI 1
• Renal ultrasound is essential to assess kidney size and echogenicity, presence of hydronephrosis, and bladder distention or thickening, as recommended by the American Institute of Ultrasound in Medicine 2
• FEUrea helps differentiate between prerenal and intrinsic causes of AKI, especially in patients receiving diuretics, with varying interpretation by clinical context 5, 6, 7
• The formula for FEUrea calculation is [(Urine urea × Serum creatinine) / (Serum urea × Urine creatinine)] × 100, with a value <28.16% indicating a high probability of pre-renal kidney insufficiency, and a sensitivity of 75% and specificity of 83% for identifying pre-renal causes 6
• FEUrea should not be used as the sole diagnostic tool, but as part of a comprehensive evaluation, with diagnostic accuracy affected in critically ill patients with sepsis, hemodynamic instability, or certain medication use 5, 6
• Comprehensive clinical assessment, including history, physical exam, and medication review, is essential for accurate AKI diagnosis 6
• Basic laboratory tests, such as serum creatinine, BUN, and urinalysis, should be used in conjunction with FEUrea as a supplementary test, not a definitive diagnostic tool 6

Prognosis and Monitoring

• The Kidney International guidelines state that interpretation of urea and creatinine levels should consider their rates of change over time, as both high and low levels can indicate poor prognosis, and 10-day mortality is higher in groups that do not achieve UXR of at least 25% 8, 7
• The International Society of Nephrology and the National Institute of Diabetes and Digestive and Kidney Diseases recommend considering urea reduction ratio (UXR) monitoring in AKI patients to assess prognosis, with UXR >25% associated with better outcomes, and patients achieving UXR >50% demonstrating the best survival 7
• The European Renal Association and the American Society of Nephrology suggest that targeting a urea reduction ratio (URR) ≥0.67 provides a simplified means of assessing adequacy of intermittent hemodialysis in AKI patients, with a greater magnitude of urea reduction ratio associated with improved patient survival in AKI 7